Stocks-AXSM-Axsome Therapeutics Inc

AXSM Axsome Therapeutics Inc

74.73 1.03 (1.40%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Stocks-AXSM-Axsome Therapeutics Inc
AXSM Axsome Therapeutics Inc
Trade

Axsome Therapeutics Inc price

-3.95% Past Week
Market Cap
3.48B
Day’s Range
72.09
-
75.32
52W Range
38.81
-
91.08
Volume (3M)
858.15K
Price-Earnings Ratio
-17.22
Revenue
182.49M

Axsome Therapeutics Inc Latest News

View All
Investing in Axsome Therapeutics Inc. (AXSM) might be an excellent idea, but the stock is currently overvalued/undervaluedInvesting in Axsome Therapeutics Inc. (AXSM) might be an excellent idea, but the stock is currently overvalued/undervaluedUS Post Newsabout 10 hours agoAxsome Therapeutics Joins The Global Narcolepsy Community In Raising Awareness On World Narcolepsy DayAxsome Therapeutics Joins The Global Narcolepsy Community In Raising Awareness On World Narcolepsy DayMENAFN Businessabout 17 hours agoRTW Investments LP Has $233.20 Million Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)RTW Investments LP Has $233.20 Million Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)The AM Reporter11 days ago
Top Discussions
MarketUpdates
United Kingdom
16 days ago
Edited
$AXSM (Axsome Therapeutics Inc) Q3 2023 earnings report is expected to be released
9
NOV
REPORTS
Axsome Therapeutics Inc Q3 2023 earnings report is expected to be released before market open
Notify me
AXSM
AXSM
Axsome Therapeutics Inc
74.73
1.03
(1.40%)
Trade
Like CommentShare
MarketUpdates
United Kingdom
28 days ago
Edited
$AXSM (Axsome Therapeutics Inc) Q3 2023 earnings report is expected to be released
undefined logo
AXSM
Axsome Therapeutics Inc
74.61
1.03 (1.40%)
Trade
Like CommentShare
MarketUpdates
United Kingdom
29 days ago
$AXSM (Axsome Therapeutics Inc) Q3 2023 earnings report is expected to be released
Like CommentShare
MarketUpdates
United Kingdom
30 days ago
Edited
$AXSM (Axsome Therapeutics Inc) Q3 2023 earnings report is expected to be released
undefined logo
AXSM
Axsome Therapeutics Inc
74.61
1.03 (1.40%)
Trade
Like CommentShare
MarketUpdates
United Kingdom
about a month ago
Edited
$AXSM (Axsome Therapeutics Inc) Q3 2023 earnings report is expected to be released
undefined logo
AXSM
Axsome Therapeutics Inc
74.61
1.03 (1.40%)
Trade
Like CommentShare

About Axsome Therapeutics Inc

Axsome Therapeutics is a New York-based pharmaceutical company founded in 2012. The firm focuses on developing and expanding treatment options for patients across the US who live with central nervous system disorders. Axsome trades under the ticker AXSM on the NASDAQ CM. Add this stock to your watchlist today to monitor AXSM price changes.
Herriott Tabuteau, MD
CEO
383
Employees
2012
Founded
New York, New York, US
HQ
Show More
Med TechNASDAQ

Upcoming Events

9
NOV
REPORTS
Axsome Therapeutics Inc Q3 2023 earnings report is expected to be released before market open

Analyst Forecast

Consensus
Moderate Buy
Price Target
129.00
Based on 2 analysts who covered AXSM 

ESG: A New Source of Insight

What is an ESG Score?
This number is a measure of a company’s exposure to environmental, social, and governance risks. Influencing factors include energy efficiency, safety, social policies, and more. Learn More
Powered by ESG Book
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
34
Very Low
Industry 
Avg. 45 
32
Environment
40
Social
27
Governance

People Also Bought